19.800
+0,00%
2026-10-19
Fundamental Analysis
52 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +23.0% | -35.8% | 2 / 3 | +3.8% | +1.79 pp | +7.06 pp | +13.0% | 0.10 | 10.16 | 286 | +3,8% | 131 | +22,7% | 10.16 | 17.86 | −43,1% |
| Pts | 4 | 0 | 8 | 0 | 8 | 12 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 19.800 (close price on 2026-10-19)EPS (TTM): 1.948
Financial charts
1.Revenue & growth
VND bn286Q2/26
1.Revenue & growth
VND bn286Q2/26
2.Profit & growth
VND bn132Q2/26
3.Profit mix (Penman)
VND bn495Q2/26
4.Margins & cost structure
%32.1%Q2/26
5.Returns & cash cycle
% · days9.2%Q2/26
6.Earnings quality & cash
VND bn121Q2/26
7.Asset structure
VND bn6.166Q2/26
8.Funding & debt health
VND bn · times6.166Q2/26
9.Revenue backlog
VND bn7,73Q2/26
10.Valuation
times · %10,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %609Q2/26
Adjusted EPS growth, latest quarter
23.0%
Average adjusted EPS growth, 3 quarters
-35.8%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26